Document Detail


Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells.
MedLine Citation:
PMID:  1412468     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In an effort to better understand the consequences of lead (Pb2+) on skeletal growth, the effects of Pb2+ were investigated using ROS 17/2.8 bone-like cells in vitro. These studies revealed that Pb2+ (4.5 x 10(-6) M -4.5 x 10(-7) M) has little or no effect on cell shape except when added immediately following seeding of the cells. However, proliferation of ROS cells was inhibited, in the absence of serum, at concentrations of 4.5 x 10(-6) M Pb2+. Protein production was generally increased, however, the major structural protein of bone, type I collagen, production was only slightly altered. Following treatment of ROS cells with Pb2+, intracellular levels of the calcium-binding protein osteonectin/SPARC were increased. Osteonectin/SPARC secretion into the media was delayed or inhibited. Coincident with retention of osteonectin/SPARC there was a decrease in the levels of osteonectin/SPARC mRNA as determined by Northern analysis. These studies suggest that processes associated with osteonectin/SPARC translation and secretion are sensitive to Pb2+.
Authors:
J J Sauk; T Smith; E K Silbergeld; B A Fowler; M J Somerman
Related Documents :
10656528 - Role of superoxide, no and oxygen in the regulation of energy metabolism and suppressio...
17077898 - Two-photon absorption of copper tetrasulfophthalocyanine induces phototoxicity towards ...
6093658 - The effect of oxygen tension on the in vitro production and release of angiotensin-conv...
17482568 - Relationship between reactive oxygen species and heme metabolism during the differentia...
18193218 - Differences in radiosensitivity between three her2 overexpressing cell lines.
3166918 - Bronchoalveolar lavage sampling of airway and alveolar cells.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Toxicology and applied pharmacology     Volume:  116     ISSN:  0041-008X     ISO Abbreviation:  Toxicol. Appl. Pharmacol.     Publication Date:  1992 Oct 
Date Detail:
Created Date:  1992-11-19     Completed Date:  1992-11-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0416575     Medline TA:  Toxicol Appl Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  240-7     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Maryland Dental School, Baltimore 21201.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Adhesion / drug effects
Cell Division / drug effects
Collagen / biosynthesis*
Endoplasmic Reticulum / metabolism
Heat-Shock Proteins / biosynthesis*
Kinetics
Lead / toxicity*
Organometallic Compounds / administration & dosage
Osteoblasts / drug effects*,  metabolism,  secretion
Osteonectin / secretion*
Osteosarcoma / metabolism,  secretion
Rats
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
AR-41572/AR/NIAMS NIH HHS; DE-08648/DE/NIDCR NIH HHS
Chemical
Reg. No./Substance:
0/Heat-Shock Proteins; 0/Organometallic Compounds; 0/Osteonectin; 301-04-2/lead acetate; 7439-92-1/Lead; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary cellular effects in rats following aerosol exposures to ultrafine Kevlar aramid fibrils: e...
Next Document:  Metabolism of benzo[a]pyrene by murine splenic cell types.